
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 28 October 2024
Sec. Thoracic Oncology
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1505996
This article is a correction to:
Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
A Corrigendum on
Prognostic Significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system
By Lee H, Lee KS, Min YW, Kim HK, Zo JI, Shim YM and Choi JY (2022). Front. Oncol. 12:861867. doi: 10.3389/fonc.2022.861867
In the published article, there was an error in Figure 2 as published. The figure legends of all four panels was reversed. The corrected Figure 2 and its caption appear below.
Figure 2. Survival curves according to SUVmax UVmax with median cutoff was a significant prognostic factor in both disease-free survival (A) and overall survival (B). SUVmax with the best cutoff to discriminate prognosis of overall survival most accurately in all patients showed the same results in both disease-free survival (C) and overall survival (D).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: esophageal cancer, squamous cell carcinoma, FDG PET/CT, prognosis, 8th AJCC staging system
Citation: Lee H, Lee KS, Min YW, Kim HK, Zo JI, Shim YM and Choi JY (2024) Corrigendum: Prognostic significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system. Front. Oncol. 14:1505996. doi: 10.3389/fonc.2024.1505996
Received: 04 October 2024; Accepted: 09 October 2024;
Published: 28 October 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, Lausanne, SwitzerlandCopyright © 2024 Lee, Lee, Min, Kim, Zo, Shim and Choi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Joon Young Choi, anlubS5jaG9pQHNhbXN1bmcuY29t
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.